Genmab Dividend yield

Genmab is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Genmab is a company from Denmark, and his stocks are publicly traded.

Genmab stock dividend

Genmab paid a total dividend of 0 million DKK last year, for a market value of 171,600 millions (Market Cap 172,187 millions). Genmab dividend per share is 0.00 DKK, and his stock market price 2,640.00 DKK.

According to the chart below where dividend yield is displayed, Genmab, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from Denmark, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Genmab might harm the evolution of share price if the company is not clearly expanding his business.

In addition, you should compare Genmab stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the high Denmark dividend stocks list.

Genmab Dividend Payout

About the ability of Genmab to maintain his current dividend of DKK 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Genmab payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

The following figure shows payout ratios over earnings and cashflow of Genmab, compared againt world market average, Denmark companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Genmab Dividend History

Below you will find a table with the historical evolution of Genmab's dividend stock, both in percentage and in DKK, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	DKK	Paypout	Shares*
Present	0.00%	0.00	0.00%	65
2022	0.00%	0.00	0.00%	65
2021	0.00%	0.00	0.00%	65
2020	0.00%	0.00	0.00%	65
2019	0.00%	0.00	0.00%	65
2018	0.00%	0.00	0.00%	61
2017	0.00%	0.00	0.00%	61
2016	0.00%	0.00	0.00%	60
2015	0.00%	0.00	0.00%	59

*In millions

Then you can see the evolution of Genmab dividend stock, and compare it with the average of Denmark stocks and that of the Pharmaceuticals and Biotechnology stocks.

Genmab Stock performance

Finally, last moth Genmab showed a return of -5.30% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a 0.00% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for Denmark and Pharmaceuticals and Biotechnology firms.